MSN: Researchers study how immunotherapy affects COVID-19 outcomes
MSN highlighted recent research from the University of Cincinnati Cancer Center on how immunotherapy treatments and immunosuppression affects the severity of COVID-19 infections for patients with cancer.
Trisha Wise-Draper, MD, PhD, co-led the research that was recently published in JAMA Oncology.
"We reviewed patients with cancer, those that had baseline immunosuppression, and those that were treated with immunotherapy prior to getting COVID-19," said Wise-Draper, associate professor of medicine in the Division of Hematology/Oncology, section head for Medical Oncology in UC’s College of Medicine, Head and Neck Center of Excellence co-leader and a UC Health physician. "The most important finding is that although those treated with immunotherapy alone did not have an effect on COVID-19 disease outcomes, those that had baseline immunosuppression and were treated with immunotherapy had worse outcomes with COVID-19."
Related Stories
UC students organize free health clinic in community
July 15, 2026
The University of Cincinnati student chapter of Remote Area Medical held its annual free health clinic July 11-12 at St. Xavier High School. Medical, dental and vision care was offered to adults and children, with no income requirements or insurance needed.
Rolling with it: Dungeons & Dragons & the University Honors Program
July 15, 2026
While Dungeons & Dragons (D&D) might not be the first activity you’d imagine engaging with through the University Honors Program (UHP), the hit tabletop role-playing game is at the center of three different honors experiences slated for the 2026-2027 academic year.
Ohio Cyber Guardian trains cyber professionals at UC’s Digital Futures
July 15, 2026
Area journalists provided coverage of Ohio Cyber Guardian 2026. The four-day event was hosted by Ohio Cyber Range Institute at the University of Cincinnati and was designed to prepare state officials and industry professionals to respond to cyber attacks.